Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer-Reference-Cited by-同舟云学术

Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer

Published:1997-10 Issue:10 Volume:8 Page:957-962
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Honkoop A.H.,van der Wall E.,Feller N.,Schuurhuis G.-J.,van der Vijgh W.J.F.,Boven E.,van Groeningen C.J.,Giaccone G.,Hoekman K.,Vermorken J.B.,Wagstaff J.,Pinedo H.M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/8/10/957/19480359/8-10-957.pdf

Reference22 articles.

1. Dose: A Critical Factor in Cancer Chemotherapy;Frei;Am J Med,1980

2. Dose intensity as a therapeutic strategy in breast cancer;Kent Osborne;Breast Cancer Res Treat,1991

3. Dose-intensive chemotherapy with doxorubicin, cyclophosphamide and GM-CSF fails to improve survival of metastatic breast cancer patients;Honkoop;Ann Oncol,1996

4. Continuous infusion or subcutaneous injection of granulocyte-macrophage colony stimulating factor; increased efficacy and reduced toxicity when given subcutaneously;Honkoop;Br J Cancer,1996

5. High dose chemotherapy in the treatment of breast cancer (Review);Honkoop;Intern J Oncol,1995

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice;Liver Research;2021-12

2. Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies;European Journal of Pharmacology;2020-01

3. A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers;Biotechnology and Bioengineering;2009-05-01

4. A novel intensive induction therapy for high-risk neuroblastoma utilizing sequential peripheral blood stem cell collection and infusion as hematopoietic support;Pediatric Blood & Cancer;2006

5. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas;Cancer;2002-09-05